# Mendelian randomization studies on the causal relationship between insomnia and disease

**Authors:** Xuan Hou, Yingjun Wei, Yongfeng Wang, Lijun Wang

PMC · DOI: 10.3389/fmed.2025.1709983 · Frontiers in Medicine · 2026-01-21

## TL;DR

This paper reviews genetic evidence showing that insomnia causes several diseases, highlighting its role as a modifiable risk factor for conditions like heart disease and diabetes.

## Contribution

A systematic integration of 105 Mendelian randomization studies reveals insomnia's causal role in various diseases, correcting observational biases.

## Key findings

- Insomnia is a robust risk factor for coronary heart disease, anxiety-depressive disorders, type 2 diabetes, and chronic pain.
- Causal relationships with osteoarthritis and lung cancer are supported but with smaller effect sizes.
- No confirmed causal link exists between insomnia and Alzheimer’s disease or schizophrenia.

## Abstract

Insomnia, a prevalent sleep disorder, poses significant threats to both physical and mental health. Traditional studies suggest multiple factors are associated with insomnia, yet the causal direction often remains unclear and susceptible to confounding biases. Mendelian randomization, a cutting-edge method leveraging genetic instrumental variables for causal inference, effectively overcomes these limitations by providing high-quality evidence to clarify causal relationships between insomnia and various diseases. This review systematically integrates 105 recent Mendelian randomization studies on insomnia. Evidence indicates that insomnia exerts clear causal effects on multiple diseases, though the strength of these associations and the robustness of evidence vary by disease type. Insomnia is a robust risk factor for coronary heart disease, anxiety-depressive disorders, type 2 diabetes, and chronic pain. Causal relationships with osteoarthritis and lung cancer are also supported, though effect sizes are relatively small. Conversely, associations with Alzheimer’s disease and schizophrenia remain unconfirmed. The studies establish a dominant causal direction from “insomnia → disease,” effectively correcting potential reverse causality bias in observational research. These findings reposition insomnia from a common symptom to a key modifiable cause of a range of psychosomatic disorders. Causal inferences grounded in genetic evidence provide a robust scientific foundation for early identification of high-risk populations, precision prevention targeting insomnia, and cross-system comorbid management.

## Linked entities

- **Diseases:** coronary heart disease (MONDO:0005010), type 2 diabetes (MONDO:0005148), osteoarthritis (MONDO:0005178), lung cancer (MONDO:0005138), Alzheimer’s disease (MONDO:0004975), schizophrenia (MONDO:0005090)

## Full-text entities

- **Diseases:** chronic pain (MESH:D059350), type 2 diabetes (MESH:D003924), lung cancer (MESH:D008175), schizophrenia (MESH:D012559), depressive disorders (MESH:D003866), osteoarthritis (MESH:D010003), Alzheimer's disease (MESH:D000544), psychosomatic disorders (MESH:D011602), Insomnia (MESH:D007319), anxiety (MESH:D001007), sleep disorder (MESH:D012893), coronary heart disease (MESH:D003327)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12867916/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12867916/full.md

## References

112 references — full list in the complete paper: https://tomesphere.com/paper/PMC12867916/full.md

---
Source: https://tomesphere.com/paper/PMC12867916